Knowledge of genomic interindividual variability could help us to explain why different manifestation of clinical severity of Covid-19 infection as well as modified pharmacogenetic relations can be expected during this pandemic condition.

Department of Pathological Physiology Faculty of Medicine Masaryk University Brno Czech Republic

See more in PubMed

ALEKSOVA A, FERRO F, GAGNO G, CAPPELLETTO C, SANTON D, ROSSI M, IPPOLITO G, ZUMLA A, BELTRAMI AP, SINAGRA G. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - is there any scientific evidence for controversy? J Intern Med. 2020 doi: 10.1111/joim.13101. PubMed DOI PMC

BITKER L, BURRELL LM. Classic and nonclassic renin-angiotensin systems in the critically ill. Crit Care Clin. 2019;35:213–227. doi: 10.1016/j.ccc.2018.11.002. PubMed DOI PMC

BOEHM M, NABEL EG. Angiotensin-converting enzyme 2 – a new cardiac regulator. New Engl J Med. 2002;347:1795–1797. doi: 10.1056/nejmcibr022472. PubMed DOI

CHIU RWK, TANG NLS, HUI DSC, CHUNG GTY, CHIM SSC, CHAN KCA, SUNG Y, CHAN LYS, TONG Y, LEE W, CHAN PKS, DENNIS LO YM. ACE2 gene polymorphisms do not affect outcome of severe acute respiratory syndrome. Clin Chem. 2004;50:1683–1689. doi: 10.1373/clinchem.2004.035436. PubMed DOI PMC

CRACKOWER MA, SARAO R, OUDIT GY. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002;417:822–828. doi: 10.1038/nature00786. PubMed DOI

GUO YR, CAO QD, HONG ZS, TAN YY, CHEN SD, JIN HJ, TAN KS, WANG DY, YAN Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res. 2020;7:1–11. doi: 10.1186/s40779-020-00240-0. PubMed DOI PMC

HAMMING I, TIMENS W, BULTHUIS ML, LELY AT, NAVIS G, Van GOOR H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631–637. doi: 10.1002/path.1570. PubMed DOI PMC

KIM MA, YANG D, KIDA K. Effects of ACE2 inhibition in the post-myocardial infarction heart. J Card Fail. 2010;16:777–785. doi: 10.1016/j.cardfail.2010.04.002. PubMed DOI PMC

KUBA K, IMAI Y, OHTO-NAKANISHI T. Trilogy of ACE2: A peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128:119–128. doi: 10.1016/j.pharmthera.2010.06.003. PubMed DOI PMC

KUBA K, IMAI Y, RAO S. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Med. 2005;11:875–879. doi: 10.1038/nm1267. PubMed DOI PMC

LI X, SUN X, JIN L, XUE F. Worldwide spatial genetic structure of angiotensin-converting enzyme gene: a new evolutionary ecological evidence for the thrifty genotype hypothesis. Eur J Hum Genet. 2011;19:1002–1008. doi: 10.1038/ejhg.2011.66. PubMed DOI PMC

LIEB W, GRAF J, GÖTZ A, KÖNIG IR, MAYER B, FISCHER M, STRITZKE J, HENGSTENBERG C, HOLMER SR, DÖRING A, LÖWEL H, SCHUNKERT H, ERDMANN J. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J Mol Med (Berl) 2006;84:88–96. doi: 10.1007/s00109-005-0718-5. PubMed DOI

LIU C, LI Y, GUAN T, LAI Y, SHEN Y, ZEYAWEIDING A, ZHAO H, LI F, MAIMAITI T. ACE2 polymorphisms associated with cardiovascular risk in Uygurs with type 2 diabetes mellitus. Cardiovasc Diabetol. 2018;17:127–138. doi: 10.1186/s12933-018-0771-3. PubMed DOI PMC

MIZUIRI S, OHASHI Y. ACE and ACE2 in kidney disease. World J Nephrol. 2015;4:74–82. doi: 10.5527/wjn.v4.i1.74. PubMed DOI PMC

PAN Y, WANG T, LI Y, GUAN T, LAI Y, SHEN Y, ZEYAWEIDING A, MAIMATI T, ZHAO H, LIU C. Association of ACE2 polymorphisms with susceptibility to essential hypertension and dyslipidemia in Xinjiang, China. Lipids Health Dis. 2018;17:241–250. doi: 10.1186/s12944-018-0890-6. PubMed DOI PMC

PATEL SK, WAI B, ORD M, MACISAAC RJ, GRANT S, VELKOSKA E, PANAGIOTOPOULOS S, JERUMS G, SRISTASAVA PM, BURRELL LM. Association of ACE2 genetic variants with blood pressure, left ventricular mass, and cardiac function in Caucasians with type 2 diabetes. Am J Hypertens. 2012;25:216–222. doi: 10.1038/ajh.2011.188. PubMed DOI

PINHEIRO DS, SANTOS RS, JARDIM PCBV, SILVA EG, REIS AAS, PEDRINO GR, ULHOA CJ. The combination of ACE I/D and ACE2 G8790A polymorphisms revels susceptibility to hypertension: A genetic association study in Brazilian patients. PLoS One. 2019;14:1–15. doi: 10.1371/journal.pone.0221248. PubMed DOI PMC

VAŠKŮ A, BIENERTOVÁ-VAŠKŮ J, PAŘENICA J, GOLDBERGOVÁ MP, LIPKOVÁ J, ZLÁMAL F, KALA P, SPINAR J. ACE2 gene polymorphisms and invasively measured central pulse pressure in cardiac patients indicated for coronarography. J Renin Angiotensin Aldosterone Syst. 2013;14:220–226. doi: 10.1177/1470320312460291. PubMed DOI

VAŠKŮ A, SOUCEK M, HÁJEK D, HOLLÁ L, ZNOJIL V, VÁCHA J. Association analysis of 24-h blood pressure records with I/D ACE gene polymorphism and ABO blood group system. Physiol Res. 1999;48:99–104. PubMed

ZHAO Q, GU D, KELLY TN, HIXSON JE, RAO DC, JAQUISH CE, CHEN J, HUANG J, CHEN CS, GU CC, WHELTON PK, HE J. Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. Am J Hypertens. 2010;23:606–613. doi: 10.1038/ajh.2010.36. PubMed DOI PMC

Alveolar type II cells and pulmonary surfactant in COVID-19 era

SARS-CoV-2 viral load assessment in lung transplantation

Androgens in SARS-CoV-2 coronavirus infections

Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression

Is there impact of the SARS-CoV-2 pandemic on steroidogenesis and fertility?

Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19

CCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects